ライフサイエンスコーパス: breast mass

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 are required to accurately evaluate a solid breast mass.

2 seroma and 7 of 83 (8%) with an isolated new breast mass.

3 lone in differentiating benign and malignant breast masses.

4 roved classification of benign and malignant breast masses.

5 diabetic mastopathy presented with palpable breast masses.

6 ng cyclosporin A therapy had newly developed breast masses.

7 benign components of small tissue samples of breast masses.

8 neck mass (4.2%), undescended testes (1.9%), breast mass (1.2%), club foot (1%), hypospadias (0.6%),

9 e range, 25-86 years) with 101 biopsy-proved breast masses (45 benign, 56 malignant).

10 approach to the detection and management of breast masses and focal asymmetries.

11 isease with expected avidity in two separate breast masses and multiple conglomerated 1-2 cm level I

12 onclusion OA/US increases the specificity of breast mass assessment compared with the device internal

13 differentiation between malignant and benign breast masses, but it should be used in conjunction with

14 f ten index surgically treatable conditions (breast mass, cleft lip/palate, club foot, hernia or hydr

15 Therefore, we hypothesized that malignant breast masses could be imaged and quantitated externally

16 a computer-aided detection (CAD) system for breast mass detection on digital breast tomosynthesis (D

17 Ultrasound-guided core needle biopsy of the breast mass diagnoses an invasive ductal carcinoma, poor

18 ethod for biopsy of radiopharmaceutical-avid breast masses guided by data from PET and SPECT scanners

19 Patients with a breast mass had worse OS and progression-free survival (

20 med in 151 consecutive solitary, nonpalpable breast masses in 151 women (age range, 23-80 years) by u

21 The US features of 31 breast masses in 23 patients were reviewed.

22 Three hundred forty-eight consecutive breast masses in 328 women who underwent image-guided or

23 Of 853 breast masses in which LCNB was performed, 38 (4%) revea

24 (age range, 17-87 years), which yielded 803 breast mass lesions (296 malignant, 507 benign).

25 Breast masses (n = 35) showed significantly higher early

26 for injuries or wounds, hernias, hydroceles, breast mass, neck mass, obstetric fistula, undescended t

27 itions (injuries/wounds, hernias/hydroceles, breast masses, neck masses, obstetric fistulas, undescen

28 hysical examination reveals neither palpable breast mass nor axillary lymphadenopathy.

29 racy in distinguishing malignant from benign breast masses on 3D US volumetric images.

30 l lymph node (SNL) mapping in a woman with a breast mass presents an unacceptable risk to her fetus.

31 ion and morphology of blood vessels in solid breast masses seen at power Doppler US is a potentially

32 y does not help determine whether a palpable breast mass should be biopsied and should not affect the

33 Material/Seventy-nine breast masses that were classified as BI-RADS category 3

34 painless breast lump and no prior history of breast masses, trauma, or surgery.

35 Nineteen patients with posterior breast masses underwent three-dimensional, gradient-echo

36 Thirty-four women with breast masses underwent US-guided biopsy with an 11-gaug

37 independent readers to benign and malignant breast masses using OA/US versus US alone.

38 US strain imaging of 403 breast masses was performed.

39 A total of 452 solid breast masses were evaluated in a surgical breast clinic

40 Seventy-three consecutive biopsies of breast masses were performed by using a 14-gauge handhel

41 Eighty-six solid breast masses, which were subsequently sampled for biops

42 Percutaneous biopsy of a nonpalpable breast mass with either US or stereotactic guidance is l

43 After removal of all US evidence of breast masses with a VAB device, there was a substantial

44 ents with Carney complex often have multiple breast masses with variable imaging appearances that pro

45 nguishing between benign and malignant solid breast masses, with biopsy results as the reference stan

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。